Renova Medical

What Renova Medical does

Renova Medical Indústria e Comércio de Produtos Médicos Hospitalares Ltda. is a privately-held Brazilian medical device company headquartered in Cravinhos, São Paulo state, with disclosed headcount of 8 employees. The firm operates a dual manufacturer-and-importer model under ANVISA Authorization 8.17.477-7, producing domestically and importing regulated medical devices for the Brazilian market. Its core product portfolio consists of disposable sterile cannulas and kits used in minimally invasive spinal interventional pain management — specifically rhizotomy (radiofrequency nerve inactivation), discectomy (disc material removal), blocking (drug infiltrations), and discography (contrast-based disc diagnosis). Standout devices include the Kit Block series (multiple gauge and length variants, 18-22G / 50-150mm) and the proprietary Kit Disco-Block, which uniquely combines diagnostic discography with peripheral nerve blocking in a single instrument; the firm also holds over 100 ANVISA product registrations covering epiduroscopy, endoscopic discectomy (DISC-A EVO), and stimulation block kits.

The company monetizes primarily through direct hardware sales of medical devices to hospitals, clinics, and medical professionals across Brazil, using a sales-led go-to-market approach with quote-based pricing (orçamento) transacted via the company website, phone, and WhatsApp. A secondary revenue stream was added in May 2020 via an exclusive distribution arrangement with Lepu Medical Technology (Beijing, China) for the SARS-CoV-2 Antibody Test (colloidal gold immunochromatography), which achieved 100% IgM and 100% IgG performance in an independent evaluation by SBAC, SBPC/ML, ABRAMED, and CBDL. The company follows ANVISA RDC 16 quality management principles and adopted an ISO 27001-aligned and LGPD-compliant data security policy in 2024.

The business is a small-scale, privately-funded entity with no disclosed institutional investors, no public revenue figures, and no public leadership roster. Its competitive position rests on a regulatory moat (extensive ANVISA registrations), a niche specialty in spinal pain devices, and the cost advantage of being both factory and importer. Risks include customer concentration uncertainty, single-country dependency, dependence on a single Chinese supplier for COVID-19 diagnostics, and limited headcount constraining sales reach.

Name

Renova Medical

Legal name

RENOVA MEDICAL INDÚSTRIA E COMÉRCIO DE PRODUTOS MÉDICOS HOSPITALARES LTDA

Website

https://renovamedical.com.br

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Renova Medical is a privately-held Brazilian manufacturer and importer of ANVISA-approved disposable medical cannulas and kits for minimally invasive spinal pain treatment (rhizotomy, discectomy, blocking, discography), also distributing COVID-19 rapid tests, serving hospitals and clinicians across Brazil.

Ownership category

akta.pro rank

Product category

Interventional Spinal Pain Management Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

• Disposable medical cannulas
• Spinal pain management
• Minimally invasive devices
• Medical device manufacturing
• Covid diagnostic tests

Headquarters

HQ city

Cravinhos

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Medical Device Manufacturing and Sales: Renova Medical manufactures and sells disposable medical cannulas and kits for spinal pain treatment procedures including rhizotomy, discectomy, blocking, and discography. Products are sold directly to healthcare providers and medical professionals in Brazil.
2. Medical Product Import and Distribution: As an ANVISA-licensed importer (Authorization 8.17.477-7), the company imports and distributes medical devices including COVID-19 rapid tests from Lepu Medical Technology (China).
3. COVID-19 Diagnostic Tests: Distribution of SARS-CoV-2 antibody rapid tests (colloidal gold immunochromatography) registered with ANVISA (registration 81747770017), sold in kit configurations of 5, 10, or 20 test devices.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Renova Medical manufactures and imports ANVISA-approved disposable medical cannulas and kits used in spinal pain treatment procedures, including rhizotomy (radiofrequency nerve inactivation), discectomy, nerve blocking, and discography. The company also distributes SARS-CoV-2 rapid antibody tests manufactured by Lepu Medical Technology under its ANVISA Class III importer/distributor license.

Product overview

Renova Medical offers a portfolio of medical devices focused on spinal pain treatment and COVID-19 diagnostics. The core products include Kit Block (disposable cannulas for nerve blocking procedures in various gauges and lengths), Kit Disco-Block (cannula kit combining discography diagnosis with nerve blocking), and a COVID-19 rapid antibody test (SARS-CoV-2 Antibody Test by Lepu Medical Technology). The company also manufactures and imports additional medical equipment including radiofrequency cannulas for rhizotomy, endoscopic discectomy kits, stimulation cannulas, and access cannulas for various spinal procedures. Products are organized under treatment categories: Rizotomia (radiofrequency nerve inactivation), Discectomia (surgical disc material removal), Bloqueio (drug infiltrations), Discografia (contrast injection diagnosis), and COVID-19 testing. The company is ANVISA-licensed (ANVISA N.3) as both a manufacturer and importer.

Differentiator

Problem solved

Functional benefit

Products and services

• Kit Block Sterile, single-use disposable cannula kit for pain blocking at targeted locations. Available in multiple gauge (18G-22G) and length (50mm-150mm) configurations. Constructed with stainless steel 304, polyethylene, and polycarbonate components. ANVISA registration 81747770009. Designed for medical professionals performing nerve blocking procedures.
• Kit Disco-Block Dual-purpose cannula kit combining discography diagnosis and peripheral nerve blocking in one product. Includes an analog manometer for internal disc pressure measurement in PSI, allowing differentiation of symptomatic from asymptomatic degenerated discs and assessment of degeneration degree and morphology. Uses a 22G access cannula and 20G blocking cannulas. ANVISA registration 81747770007.
• SARS-CoV-2 Antibody Rapid Test (COVID-19 Rapid Test) Rapid antibody test for SARS-CoV-2 (COVID-19) using colloidal gold immunochromatography, detecting IgM and IgG antibodies. Manufactured by Lepu Medical Technology and distributed by Renova Medical in kits of 5, 10, or 20 test devices. ANVISA registration 81747770017. Achieved 100% IgM and 100% IgG performance in an independent Brazilian evaluation program supported by LSHTM IDC and WHO.

Quantifiable outcome

• 100% IgM and 100% IgG performance in SARS-CoV-2 antibody test evaluation by SBAC, SBPC/ML, ABRAMED, CBDL, supported by LSHTM IDC and WHO
• +2 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Lepu Medical Technology (Beijing) Co., Ltd.coreTechnology or Integration · 20 May 2020Lepu Medical Technology (Beijing, China) is the manufacturer of the SARS-CoV-2 Antibody Test distributed by Renova Medical in Brazil. Renova Medical holds ANVISA authorization to import and distribute Class III in vitro diagnostic products manufactured by Lepu. The partnership involves product registration (ANVISA 81747770017), import authorization (8.17.477-7), and Good Manufacturing Practices certification from ANVISA.
• SBAC, SBPC/ML, ABRAMED, CBDL (Brazilian diagnostic associations)coreStrategic or Co-development Partner · 20 May 2020Brazilian clinical analysis societies jointly evaluated COVID-19 diagnostic kits available in the Brazilian market. Renova Medical's Lepu test achieved the best performance (100% IgM and 100% IgG) in this evaluation program. The initiative is supported by international organizations including the International Diagnostic Centre (IDC) of the London School of Hygiene & Tropical Medicine, ALADDIV, the European Union, and WHO.
• ANVISA (Agência Nacional de Vigilância Sanitária)coreOthersANVISA is Brazil's national health regulatory agency. Renova Medical operates under ANVISA Authorization 8.17.477-7 and holds over 100 ANVISA product registrations for medical devices and in vitro diagnostic products. The company follows RDC 16 quality management guidelines and undergoes Good Manufacturing Practices certification.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Elliquence: US-based company developing minimally invasive spine surgery technologies, including RF-based endoscopic tools for nerve ablation and disc procedures. Comparable to Renova's RENOVA RF cannula kits for rhizotomy and the nerve ablation segment of its pain management portfolio.
• Joimax: German medical device company focused on endoscopic minimally invasive spine surgery, including endoscopic discectomy systems. Directly comparable to Renova's DISC-A EVO percutaneous endoscopic discectomy kit and broader discectomy cannula portfolio.
• Vertos Medical: US-based medical device company specializing in minimally invasive interventional treatments for lumbar spinal stenosis (mild procedure). Comparable to Renova as both focus on disposable, minimally invasive instruments used by interventional pain specialists for outpatient spinal procedures.

Broad incumbents

• Boston Scientific: Global medical device major with an interventional pain management portfolio including RF generators (formerly Cosman), spinal cord stimulation, and Vertiflex. Broadly comparable to Renova in interventional pain and spine, though Boston Scientific operates across many other therapy areas with much greater scale.
• Stryker: Global medical device company with a substantial Spine division covering interventional pain, discectomy, and minimally invasive spine products. Comparable to Renova in product category but vastly larger in scale and global reach.
• Smith & Nephew: Global medical technology company with a Sports Medicine & ENT division including RF ablation and endoscopic spine products. Comparable to Renova in RF cannula and minimally invasive spine offerings, though operates at far greater scale across orthopedics and wound care.
• Medtronic: Global medical device leader with a Pain Therapies division offering spinal cord stimulation, RF ablation, and intrathecal drug delivery. Comparable to Renova in interventional pain management, though Medtronic operates at multibillion-dollar scale across multiple therapy areas.
• Abbott: Global healthcare major with a Neuromodulation division offering spinal cord stimulation and RF ablation for chronic pain. Comparable to Renova in the interventional pain management category, though Abbott operates across diagnostics, devices, nutrition, and pharmaceuticals at massive scale.

Regional players

• GMReis: Brazilian medical device company specializing in orthopedic implants and surgical instruments for spine, trauma, and arthroplasty. Comparable to Renova as a domestic Brazilian manufacturer selling spine-related medical devices through direct relationships with Brazilian hospitals and surgeons.

Emerging players

• Captiva Spine: US-based privately-held spinal device company focused on minimally invasive and motion-preserving spine technologies. Comparable to Renova as a smaller, specialized player in the spinal intervention space with a focused product portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/renova-medical

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Renova Medical